Keywords: vectura, ed, drug, impresses, 2nd, ph, iib

Vectura's ED drug impresses in 2nd Ph IIb study

Article | 30 April 2007

Print This

Vectura, a UK drugmaker focused on the development of inhaled drug formulations for the treatment of both lung diseases and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in